Gynesonics out of Redwood City, California has receive EU’s CE Mark of approval for the firm’s VizAblate system. VizAblate uses ultrasound to locate uterine fibroids and a multi-prong radiofrequency antenna to ablate them.
From the announcement:
The VizAblate™ System is intended to provide gynecologists with an incision-less procedure for the treatment of uterine fibroids associated with heavy menstrual bleeding. The VizAblate™ System is a transcervical device that combines ultrasound image guidance with radiofrequency ablation to treat fibroids in an outpatient setting.
Here’s a one minute animation demonstrating the workings of the VizAblate:
Press release: Gynesonics Receives the CE-Mark for the VizAblate™ System to Treat Uterine Fibroids…
Gynesonics homepage…